A phase III, multicentre, randomised, double-blind, active-controlled, parallel-group trial comparing safety and efficacy of HD203, with innovator etanercept, in combination with methotrexate, in patients with rheumatoid arthritis: The HERA study

Sang Cheol Bae, Jinseok Kim, Jung Yoon Choe, Won Park, Sang Heon Lee, Yong Beom Park, Seung Cheol Shim, Shin Seok Lee, Yoon Kyoung Sung, Chan Bum Choi, So Ra Lee, Hanyu Park, Yongho Ahn

Research output: Contribution to journalArticle

24 Citations (Scopus)

Fingerprint Dive into the research topics of 'A phase III, multicentre, randomised, double-blind, active-controlled, parallel-group trial comparing safety and efficacy of HD203, with innovator etanercept, in combination with methotrexate, in patients with rheumatoid arthritis: The HERA study'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds